Search research articles
Contact Us
Filters
Showing results (41-50 of 47) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 47 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 22, 2025
US Food and Drug Administration Approval Summary: Inavolisib With Palbociclib and Fulvestrant for Endocrine-Resistant, <i>PIK3CA</i>-Mutated, Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, Locally Advanced or Metastatic Breast Cancer
Suparna Wedam, Preeti Narayan, Haley Gittleman, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
August 28, 2019
Overcoming anti-PEG antibody mediated accelerated blood clearance of PEGylated liposomes by pre-infusion with high molecular weight free PEG
Morgan D McSweeney, Lauren S L Price, Timothy Wessler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 2, 2023
FDA Approval Summary: Selpercatinib for the Treatment of Advanced RET Fusion-Positive Solid Tumors
Elizabeth S Duke, Diana Bradford, Michelle Marcovitz, et al.
Neuro-Oncology
|
March 12, 2026
Evaluating "Brain Permeability": A Critical Issue for the Development of Therapeutic Agents for Primary and Metastatic Brain Tumors
Stuart A Grossman, Amy Barone, Roy E Strowd, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 26, 2020
FDA Approval Summary: Selpercatinib for the Treatment of Lung and Thyroid Cancers with <i>RET</i> Gene Mutations or Fusions
Diana Bradford, Erin Larkins, Sirisha L Mushti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 27, 2025
FDA Approval Summary: Datopotamab deruxtecan-dlnk for treatment of patients with unresectable or metastatic, HR-positive, HER2-negative breast cancer
Melanie Royce, Mirat Shah, Lijun Zhang, et al.
Acta Crystallographica. Section B, Structural Science
|
September 28, 2005
A third blind test of crystal structure prediction
G M Day, W D S Motherwell, H L Ammon, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 47) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 47 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 22, 2025
US Food and Drug Administration Approval Summary: Inavolisib With Palbociclib and Fulvestrant for Endocrine-Resistant, <i>PIK3CA</i>-Mutated, Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, Locally Advanced or Metastatic Breast Cancer
Suparna Wedam, Preeti Narayan, Haley Gittleman, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
August 28, 2019
Overcoming anti-PEG antibody mediated accelerated blood clearance of PEGylated liposomes by pre-infusion with high molecular weight free PEG
Morgan D McSweeney, Lauren S L Price, Timothy Wessler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 2, 2023
FDA Approval Summary: Selpercatinib for the Treatment of Advanced RET Fusion-Positive Solid Tumors
Elizabeth S Duke, Diana Bradford, Michelle Marcovitz, et al.
Neuro-Oncology
|
March 12, 2026
Evaluating "Brain Permeability": A Critical Issue for the Development of Therapeutic Agents for Primary and Metastatic Brain Tumors
Stuart A Grossman, Amy Barone, Roy E Strowd, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 26, 2020
FDA Approval Summary: Selpercatinib for the Treatment of Lung and Thyroid Cancers with <i>RET</i> Gene Mutations or Fusions
Diana Bradford, Erin Larkins, Sirisha L Mushti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 27, 2025
FDA Approval Summary: Datopotamab deruxtecan-dlnk for treatment of patients with unresectable or metastatic, HR-positive, HER2-negative breast cancer
Melanie Royce, Mirat Shah, Lijun Zhang, et al.
Acta Crystallographica. Section B, Structural Science
|
September 28, 2005
A third blind test of crystal structure prediction
G M Day, W D S Motherwell, H L Ammon, et al.
Page
of 5